CCR 20th Anniversary Commentary: Prospects and Challenges of Therapeutic Nanoparticles in Cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26473185.
- Also identified by DOI 10.1158/1078-0432.CCR-14-3126 and PMC identifier 4610251.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In their review article published in the March 1, 2008, issue of Clinical Cancer Research, Cho and colleagues presented the strong potential of nanotechnology in cancer. This commentary discusses the latest advances in nanotechnology, which provide novel approaches for cancer diagnosis, imaging, drug delivery, and personalized therapy; highlights the perspectives for therapeutic nanoparticles; and describes the advantages and challenges of their multifunctionalities.
Medical subject headings
- Antineoplastic Agents
- Drug Delivery Systems
- Nanoparticles
- Neoplasms